Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis

BACKGROUND: Ulcerative colitis is a chronic immune-mediated inflammatory condition of the large intestine and rectum. Several targeted immune modulators (TIMs) have demonstrated effectiveness for the treatment of moderate to severe ulcerative colitis and are approved by the FDA. Patients may try mul...

Descripción completa

Detalles Bibliográficos
Autores principales: Bloudek, Lisa M, Pandey, Rajshree, Fazioli, Katherine, Ollendorf, Daniel A, Carlson, Josh J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390993/
https://www.ncbi.nlm.nih.gov/pubmed/34337994
http://dx.doi.org/10.18553/jmcp.2021.27.8.1046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390993/
https://www.ncbi.nlm.nih.gov/pubmed/34337994
http://dx.doi.org/10.18553/jmcp.2021.27.8.1046

Ejemplares similares